The purpose of this study is to evaluate if lidocaine-prilocaine (EMLA 5%) cream can reduce
pain and discomfort at the time of vaginal pessary removal and insertion. Half of the
participants will receive lidocaine-prilocaine (EMLA 5%) cream and the other half will
receive a placebo cream.
Lidocaine-prilocaine (EMLA 5%) cream has been shown to be effective in reducing pain during
minor gynecologic procedures. The primary objective of this trial is to determine if the use
of 5% EMLA cream at the time of pessary removal and insertion reduces pain when compared to
the use of placebo cream.
Participants will be randomized to receive either 10 grams of 5% EMLA cream (4 mL) or 4 mL
of placebo cream (aqueous cream BP). Cream will be applied in office at the time of pessary
removal and insertion.
- Women in the Loyola Urogynecology clinic who use a pessary for management of pelvic
organ prolapse (POP) or urinary incontinence (UI)
- Read and speak the English language
- Non-English speaking
- Allergy or contraindication to topical anesthetic
- Participation/randomization in the study at a previous visit
- Currently pregnant or lactating or planning a pregnancy within the next 6 months